Compound Detail
CHEMBL483158
ALISERTIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O
Basic Information
| ChEMBL ID | CHEMBL483158 |
| Name | ALISERTIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | ZLHFILGSQDJULK-UHFFFAOYSA-N |
60
Targets
119
Activities
4
Assay Types
5
PK Parameters
20
Publications
4
Known Names
20
Indications
1
Mechanisms
Molecular Properties
518.9
MW (Da)
5.75
ALogP
7
HBA
2
HBD
105.9
PSA (Ų)
0.33
QED
2
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase Aurora-A inhibitor | INHIBITOR | Aurora kinase A | ✓ | ✓ |
Indications
Lymphoma, T-Cell, Peripheral Breast Neoplasms Breast Neoplasms Breast Neoplasms Fallopian Tube Neoplasms Leukemia, Myeloid, Acute Myelodysplastic Syndromes Ovarian Neoplasms Peritoneal Neoplasms Prostatic Neoplasms Small Cell Lung Carcinoma Urinary Bladder Neoplasms Burkitt Lymphoma Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Digestive System Neoplasms Head and Neck Neoplasms Lymphoma Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse
Activity Summary
IC50 59 meas. best 10.4
Ki 40 meas. best 9.52
Kd 19 meas. best 8.3
EC50 1 meas. best 7.39
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Aurora kinase A CHEMBL4722 | IC50 | 10.4 | 8.1193 | 0.0 | 30 |
| Aurora kinase A CHEMBL2211 | Ki | 9.52 | 9.52 | 0.3 | 1 |
| Aurora kinase A CHEMBL4722 | Ki | 9.3 | 9.3 | 0.5 | 1 |
| Aurora kinase A CHEMBL2211 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
| Aurora kinase B/Inner centromere protein CHEMBL3430907 | IC50 | 8.96 | 8.96 | 1.1 | 1 |
| MV4-11 CHEMBL613835 | IC50 | 8.92 | 8.92 | 1.2 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.52 | 8.52 | 3.0 | 1 |
| Aurora kinase B CHEMBL2185 | Ki | 8.5 | 8.5 | 3.2 | 1 |
| Aurora kinase A CHEMBL4722 | Kd | 8.3 | 8.3 | 5.0 | 1 |
| Ephrin type-A receptor 2 CHEMBL2068 | Ki | 7.5 | 7.5 | 31.6 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.41 | 6.971 | 39.0 | 10 |
| Tyrosine-protein kinase Blk CHEMBL2250 | Ki | 7.4 | 7.4 | 39.8 | 1 |
| Serine/threonine-protein kinase PLK4 CHEMBL3788 | Ki | 7.4 | 7.4 | 39.8 | 1 |
| Unchecked CHEMBL612545 | EC50 | 7.39 | 7.39 | 40.9 | 1 |
| Acyl-CoA dehydrogenase family member 10 CHEMBL4105816 | Kd | 7.11 | 7.11 | 78.0 | 1 |
| Aurora kinase B CHEMBL2185 | IC50 | 7.05 | 6.3656 | 90.0 | 9 |
| Tyrosine-protein kinase FRK CHEMBL4223 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| Tyrosine-protein kinase Fer CHEMBL3982 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| NCI-H358 CHEMBL614135 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 CHEMBL2534 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| Focal adhesion kinase 1 CHEMBL2695 | Ki | 6.9 | 6.9 | 125.9 | 1 |
| Proto-oncogene tyrosine-protein kinase ROS CHEMBL5568 | Ki | 6.8 | 6.8 | 158.5 | 1 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 CHEMBL4105887 | Kd | 6.74 | 6.74 | 184.0 | 1 |
| Aurora kinase B CHEMBL2185 | Kd | 6.71 | 6.71 | 195.0 | 1 |
| Fibroblast growth factor receptor 3 CHEMBL2742 | Ki | 6.7 | 6.7 | 199.5 | 1 |
| Epidermal growth factor receptor CHEMBL203 | Ki | 6.7 | 6.7 | 199.5 | 1 |
| Unchecked CHEMBL612545 | Kd | 6.54 | 5.98 | 289.0 | 2 |
| Ephrin type-A receptor 2 CHEMBL2068 | Kd | 6.51 | 6.51 | 309.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | Ki | 6.5 | 6.5 | 316.2 | 1 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | Ki | 6.5 | 6.5 | 316.2 | 1 |
| Tyrosine-protein kinase Lck CHEMBL258 | IC50 | 6.5 | 6.5 | 320.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | Ki | 6.5 | 6.5 | 316.2 | 1 |
| Tyrosine-protein kinase Lck CHEMBL258 | Ki | 6.5 | 6.5 | 316.2 | 1 |
| HT-29 CHEMBL384 | IC50 | 6.48 | 6.48 | 330.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | Ki | 6.4 | 6.4 | 398.1 | 1 |
| NT-3 growth factor receptor CHEMBL5608 | Ki | 6.4 | 6.4 | 398.1 | 1 |
| Leukocyte tyrosine kinase receptor CHEMBL5627 | Ki | 6.4 | 6.4 | 398.1 | 1 |
| Ephrin type-A receptor 4 CHEMBL3988 | Kd | 6.34 | 6.34 | 455.0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 CHEMBL1962 | IC50 | 6.31 | 6.31 | 490.0 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | Ki | 6.3 | 6.3 | 501.2 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | Ki | 6.2 | 6.2 | 631.0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha CHEMBL4101 | Ki | 6.2 | 6.2 | 631.0 | 1 |
| DNA replication licensing factor MCM4 CHEMBL4105745 | Kd | 6.2 | 6.2 | 629.0 | 1 |
| Activated CDC42 kinase 1 CHEMBL4599 | Ki | 6.1 | 6.1 | 794.3 | 1 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | Ki | 6.1 | 6.1 | 794.3 | 1 |
| Ribosomal protein S6 kinase alpha-3 CHEMBL2345 | Ki | 6.1 | 6.1 | 794.3 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 CHEMBL1075104 | Ki | 6.1 | 6.1 | 794.3 | 1 |
| DnaJ homolog subfamily A member 1 CHEMBL2189122 | Kd | 6.02 | 6.02 | 962.0 | 1 |
| Tyrosine-protein kinase ABL2 CHEMBL4014 | Kd | 6.0 | 6.0 | 1009.0 | 1 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | Ki | 6.0 | 6.0 | 1000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 201000.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 10.4 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 92498.02 | nM | Rattus norvegicus |
| F | 124.0 | % | Rattus norvegicus |
| T1/2 | 7.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724801 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5058577 | U2OS | 304 |
| - | 10.6019/CHEMBL5724801 | U2OS | 304 |
| - | 10.6019/CHEMBL5724801 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5724696 | U2OS | 16 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| 26101564 | 10.1021/ml500409n | Rattus norvegicus | 11 |
| 25625617 | 10.1021/jm501599u | NON-PROTEIN TARGET | 10 |
| - | 10.6019/CHEMBL5058564 | U2OS | 9 |
| 26254279 | 10.18632/oncotarget.4214 | Aurora kinase A | 9 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 9 |
| 34009981 | 10.1021/acs.jmedchem.0c01806 | Unchecked | 8 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 8 |
| - | 10.6019/CHEMBL5444388 | Aurora kinase A | 6 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| - | 10.1158/2159-8290.CD-23-0050 | Colon cancer organoid | 5 |
Data from ChEMBL 36 via Core Engine